Office-based Denver peritoneovenous shunt for malignant ascites: A feasibility study

expectation, unresponsive to diuretic treatment, and requiring paracentesis at least twice a week were evaluated for shunt placement. Of these, 98 patients (8 with breast cancer carcinomatosis, 5 with pancreatic cancer carcinomatosis, 30 with ovarian cancer carcinomatosis, 15 with gastric cancer carcinomatosis, 30 with colorectal cancer carcinomatosis, 5 with abdominal mesothelioma, 5 with carcinomatosis of other origin) with a cardiac ejection fraction >40 and Karnofsky Performance Status >80 received a Denver peritoneojugular shunt as an outpatient procedure under local anesthesia and mild sedation. Jugular vascular access was achieved via ultrasound-guided venipuncture.